Edeline, J. et al. (2016) A multicenter comparison between Child Pugh and ALBI scores in patients treated with sorafenib for hepatocellular carcinoma. Liver International, 36(2), pp. 1821-1828. (doi:10.1111/liv.13170) This is the author's final accepted version.There may be differences between this version and the published version. You are advised to consult the publisher's version if you wish to cite from it.http://eprints.gla.ac.uk/119466/

Adoptive transfer of antigen-specific T lymphocytes is an effective form of immunotherapy for persistent virus infections and cancer. A major limitation of adoptive therapy is the inability to isolate antigen-specific T lymphocytes reproducibly. The demonstration that cloned T-cell receptor (TCR) genes can be used to produce T lymphocyte populations of desired specificity offers new opportunities for antigen-specific T-cell therapy. TCR gene-modified lymphocytes display antigen-specific function in vitro, and were shown to protect against virus infection and tumor growth in animal models. A recent trial in humans demonstrated that TCR gene-modified T cells persisted in all and reduced melanoma burden in 2/15 patients. In future trials, it may be possible to use TCR gene transfer to equip helper and cytotoxic T cells with new antigen-specificity, allowing both T-cell subsets to cooperate in achieving improved clinical responses. Sequence modifications of TCR genes are being explored to enhance TCR surface expression, while minimizing the risk of pairing between introduced and endogenous TCR chains. Current T-cell transduction protocols that trigger T-cell differentiation need to be modified to generate "undifferentiated" T cells, which, upon adoptive transfer, display improved in vivo expansion and survival. Both, expression of only the introduced TCR chains and the production of naïve T cells may be possible in the future by TCR gene transfer into stem cells.

No abstract

No abstract

Abudu, S., J.P. King, Z. Sheng, 2011. Comparison of the Performance of Statistical Models in Forecasting Monthly Total Dissolved Solids in the Rio Grande. Journal of the American Water Resources Association (JAWRA) 48(1): 10‐23. DOI: 10.1111/j.1752‐1688.2011.00587.x Abstract:  This paper presents the application of autoregressive integrated moving average (ARIMA), transfer function‐noise (TFN), and artificial neural networks (ANNs) modeling approaches in forecasting monthly total dissolved solids (TDS) of water in the Rio Grande at El Paso, Texas. Predictability analysis was performed between the precipitation, temperature, streamflow rates at the site, releases from upstream reservoirs, and monthly TDS using cross‐correlation statistical tests. The chi‐square test results indicated that the average monthly temperature and precipitation did not show significant predictability on monthly TDS series. The performances of one‐ to three‐month‐ahead model forecasts for the testing period of 1984‐1994 showed that the TFN model that incorporated the streamflow rates at the site and Caballo Reservoir release improved monthly TDS forecasts slightly better than the ARIMA models. Except for one‐month‐ahead forecasts, the ANN models using the streamflow rates at the site as inputs resulted in no significant improvements over the TFN models at two‐month‐ahead and three‐month‐ahead forecasts. For three‐month‐ahead forecasts, the simple ARIMA showed similar performance compared to all other models. The results of this study suggested that simple deseasonalized ARIMA models could be used in one‐ to three‐month‐ahead TDS forecasting at the study site with a simple, explicit model structure and similar model performance as the TFN and ANN models for better water management in the Basin.

Storage and release functions of western U.S. traditional river valley irrigation systems may counteract early and rapid spring river runoff associated with climate variation. Along the Rio Grande in northern New Mexico, we instrumented a 20-km-long irrigated valley to measure water balance components from 2005 to 2007. Hydrologic processes of the system were incorporated into a system dynamics model to test scenarios of changed water use. Of river water diverted into an earthen irrigation canal system, some was consumed by crop evapotranspiration ͑7.4%͒, the rest returned to the river as surface return flow ͑59.3%͒ and shallow groundwater return flow that originated as seepage from canals ͑12.1%͒ and fields ͑21.2%͒. The modeled simulations showed that the coupled surface water irrigation system and shallow aquifer act together to store water underground and then release it to the river, effectively retransmitting river flow until later in the year. Water use conversion to nonirrigation purposes and reduced seepage from canals and fields will likely result in higher spring runoff and lower fall and winter river flow.

No abstract

Objective. Fertility preservation is an important survivorship issue for women treated for breast cancer. The aim of this work was to examine the referral practices of health care professionals who treat women with breast cancer in the United Kingdom, and to investigate their understanding and knowledge of the fertility preservation options available.Method. An invitation to participate in a confidential, online questionnaire was e-mailed to surgeons, oncologists, and clinical nurse specialists who manage patients with breast cancer in the United Kingdom.Results. n ‫؍‬ 306 respondents. Factors which influenced whether fertility preservation options were discussed with a patient included the following: patient's age (78%), final tumor/nodes/metastasis status (37.9%); concern that fertility preservation would delay chemotherapy (37.3%); whether the patient had children (33.5%) or a partner (24.7%); estrogen receptor expression (22.6%), lack of knowledge regarding the available options (20.9%); and concern that fertility preservation would compromise the success of cancer treatment (19.8%). Twenty-seven percent did not know whether fertility preservation was available for their patients on the National Health Service. Nearly half (49.4%) of respondents said that gonadotropin-releasing hormone agonists were used for fertility preservation outside the setting of a clinical trial. Knowledge regarding the available options varied according to different members of the multidisciplinary team, with consultant oncologists better informed than consultant surgeons or clinical nurse specialists (p < .05).Conclusions. Many health care professionals have incomplete knowledge regarding the local arrangements for fertility preservation for patients with breast cancer. This may result in patients receiving inadequate or conflicting information regarding fertility preservation. The Oncologist 2012;17:910 -916